发明名称 Development of dengue virus vaccine components
摘要 The invention is related to a dengue virus or chimeric dengue virus that contains a mutation in the 3' untranslated region (3'-UTR) comprising a ”30 mutation that removes the TL-2 homologous structure in each of the dengue virus serotypes 1, 2, 3, and 4, and nucleotides additional to the ”30 mutation deleted from the 3'-UTR that removes sequence in the 5' direction as far as the 5' boundary of the TL-3 homologous structure in each of the dengue virus serotypes 1, 2, 3, and 4, or a replacement of the 3'-UTR of a dengue virus of a first serotype with the 3'-UTR of a dengue virus of a second serotype, optionally containing the ”30 mutation and nucleotides additional to the ”30 mutation deleted from the 3'-UTR; and immunogenic compositions, methods of inducing an immune response, and methods of producing a dengue virus or chimeric dengue virus.
申请公布号 PL2589602(T3) 申请公布日期 2016.11.30
申请号 PL12182319T 申请日期 2007.08.15
申请人 发明人 WHITEHEAD STEPHEN S.;BLANEY JOSEPH E.;MURPHY BRIAN R.;CHING-JUH LAI
分类号 主分类号
代理机构 代理人
主权项
地址